BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36754369)

  • 1. Peritoneal transformation shortly after kidney transplantation in pediatric patients with preceding chronic peritoneal dialysis.
    Zhang C; Bartosova M; Marinovic I; Schwab C; Schaefer B; Vondrak K; Ariceta G; Zaloszyc A; Ranchin B; Taylan C; Büscher R; Oh J; Mehrabi A; Schmitt CP
    Nephrol Dial Transplant; 2023 Sep; 38(10):2170-2181. PubMed ID: 36754369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.
    Schaefer B; Bartosova M; Macher-Goeppinger S; Sallay P; Vörös P; Ranchin B; Vondrak K; Ariceta G; Zaloszyc A; Bayazit AK; Querfeld U; Cerkauskiene R; Testa S; Taylan C; VandeWalle J; Yap Y; Krmar RT; Büscher R; Mühlig AK; Drozdz D; Caliskan S; Lasitschka F; Fathallah-Shaykh S; Verrina E; Klaus G; Arbeiter K; Bhayadia R; Melk A; Romero P; Warady BA; Schaefer F; Ujszaszi A; Schmitt CP
    Kidney Int; 2018 Aug; 94(2):419-429. PubMed ID: 29776755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal Dialysis Vintage and Glucose Exposure but Not Peritonitis Episodes Drive Peritoneal Membrane Transformation During the First Years of PD.
    Bartosova M; Schaefer B; Vondrak K; Sallay P; Taylan C; Cerkauskiene R; Dzierzega M; Milosevski-Lomic G; Büscher R; Zaloszyc A; Romero P; Lasitschka F; Warady BA; Schaefer F; Ujszaszi A; Schmitt CP
    Front Physiol; 2019; 10():356. PubMed ID: 31001140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
    Park SH; Lee EG; Kim IS; Kim YJ; Cho DK; Kim YL
    Perit Dial Int; 2004; 24(2):115-22. PubMed ID: 15119632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors increasing severity of peritonitis in long-term peritoneal dialysis patients.
    Park MS
    Adv Ren Replace Ther; 1998 Jul; 5(3):185-93. PubMed ID: 9686629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do low GDP neutral pH solutions prevent or retard peritoneal membrane alterations in long-term peritoneal dialysis?
    Parikova A; Michalickova K; van Diepen AT; Voska L; Viklicky O; Krediet RT
    Perit Dial Int; 2022 May; 42(3):236-245. PubMed ID: 34259088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
    Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
    BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediators of inflammation and fibrosis.
    Lai KN; Tang SC; Leung JC
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S65-71. PubMed ID: 17556333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on mechanisms of ultrafiltration failure.
    Kim YL
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S123-7. PubMed ID: 19270200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bicarbonate buffered peritoneal dialysis fluid upregulates angiopoietin-1 and promotes vessel maturation.
    Eich G; Bartosova M; Tischer C; Wlodkowski TT; Schaefer B; Pichl S; Kraewer N; Ranchin B; Vondrak K; Liebau MC; Hackert T; Schmitt CP
    PLoS One; 2017; 12(12):e0189903. PubMed ID: 29253861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatibility of peritoneal dialysis fluids: long-term exposure of nonuremic rats.
    Musi B; Braide M; Carlsson O; Wieslander A; Albrektsson A; Ketteler M; Westenfeld R; Floege J; Rippe B
    Perit Dial Int; 2004; 24(1):37-47. PubMed ID: 15104335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cell transplantation may provide a new therapy for ultrafiltration failure in chronic peritoneal dialysis.
    Bastug F; Gündüz Z; Tülpar S; Torun YA; Akgün H; Dörterler E; Düsünsel R; Poyrazoglu H; Bastug O; Dursun I; Yel S
    Nephrol Dial Transplant; 2013 Oct; 28(10):2493-501. PubMed ID: 23880789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of peritoneal dialysis in the first weeks after catheter insertion: A comparison of a neutral-pH, low-GDP PD fluid and a conventional PD fluid
.
    Farhat K; van Ittersum FJ; Ter Wee PM; Paauw NJ; Beelen RHJ; Douma CE
    Clin Nephrol; 2018 Feb; 89(2):75-82. PubMed ID: 28992851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatible dialysis fluids for peritoneal dialysis.
    Htay H; Johnson DW; Wiggins KJ; Badve SV; Craig JC; Strippoli GF; Cho Y
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007554. PubMed ID: 30362116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term intervention with heparins in a rat model of peritoneal dialysis.
    Schilte MN; Loureiro J; Keuning ED; ter Wee PM; Celie JW; Beelen RH; van den Born J
    Perit Dial Int; 2009; 29(1):26-35. PubMed ID: 19164250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal equilibration test with conventional 'low pH/high glucose degradation product' or with biocompatible 'normal pH/low glucose degradation product' dialysates: does it matter?
    Van Overmeire L; Goffin E; Krzesinski JM; Saint-Remy A; Bovy P; Cornet G; Bovy C
    Nephrol Dial Transplant; 2013 Jul; 28(7):1946-51. PubMed ID: 23223220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties.
    Plum J; Hermann S; Fusshöller A; Schoenicke G; Donner A; Röhrborn A; Grabensee B
    Kidney Int Suppl; 2001 Feb; 78():S42-7. PubMed ID: 11168981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis.
    Marchant V; Tejera-Muñoz A; Marquez-Expósito L; Rayego-Mateos S; Rodrigues-Diez RR; Tejedor L; Santos-Sanchez L; Egido J; Ortiz A; Valdivielso JM; Fraser DJ; López-Cabrera M; Selgas R; Ruiz-Ortega M
    Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32987705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesothelial cell transplantation in models of acute inflammation and chronic peritoneal dialysis.
    Hekking LH; Harvey VS; Havenith CE; van den Born J; Beelen RH; Jackman RW; Nagy JA
    Perit Dial Int; 2003; 23(4):323-30. PubMed ID: 12968839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatible dialysis fluids for peritoneal dialysis.
    Cho Y; Johnson DW; Craig JC; Strippoli GF; Badve SV; Wiggins KJ
    Cochrane Database Syst Rev; 2014 Mar; (3):CD007554. PubMed ID: 24671928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.